Merck, Eisai Win FDA Approval for Combination Treatment for Advanced Endometrial Carcinoma | BioSpace

biospace.com - Merck’s venerable checkpoint inhibitor Keytruda picked up another regulatory approval. On Wednesday, the U.S. Food and Drug Administration (FDA) approved Keytruda in combination with Eisai’s Lenvima …

Tweeted by @Rectitude20 https://twitter.com/Rectitude20/status/1174410910657601536